Skip to content

Prophylactic Norepinephrine and Phenylephrine Infusion for Hemodynamic Effects in Patients With Preeclampsia

Comparison of Prophylactic Norepinephrine and Phenylephrine Infusion for Hemodynamic Effects in Patients With Preeclampsia During Cesarean Section: a Randomized, Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05035498
Enrollment
72
Registered
2021-09-05
Start date
2024-02-01
Completion date
2025-04-21
Last updated
2024-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hemodynamic Instability

Keywords

Norepinephrine, Phenylephrine, Hemodynamic effects, Preeclampsia, Cesarean section

Brief summary

The purpose of this study is to investigate the maternal cardiac output response to prophylactic norepinephrine and phenylephrine infusion for postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Detailed description

Preeclampsia, which affects 5% to 7% of parturients, is a significant cause of maternal and neonatal morbidity and mortality. Because of constricted myometrial spiral arteries with exaggerated vasomotor responsiveness, though blood pressure in parturients with preeclampsia are apparently higher than healthy parturients, placental hypoperfusion is more common. Spinal anesthesia is still the preferred mode of anesthesia in parturients with preeclampsia for cesarean section. In preeclampsia parturients, spinal anesthesia improve intervillous blood flow (provided that hypotension is avoided) which contribute to increase placental perfusion. Even so, 17-26% parturients with preeclampsia experienced postspinal anesthesia hypotension due to the extensive sympathetic block that occurred with spinal anesthesia. As a potential substitute drug for phenylephrine and ephedrine, norepinephrine has gained traction for use in parturients undergoing cesarean section. However, hemodynamic effects of the prophylactic norepinephrine infusion is still unknown. The purpose of this study is to investigate the maternal cardiac output response to prophylactic norepinephrine and phenylephrine infusion for postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Interventions

DRUGNorepinephrine

A maintenance dose of norepinephrine (0.05 μg/kg/min) infusion simultaneous with subarachnoid block

DRUGPhenylephrine

A maintenance dose of phenylephrine (0.625 μg/kg/min) infusion simultaneous with subarachnoid block

Sponsors

General Hospital of Ningxia Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* 18-45 years * Primipara or multipara * Singleton pregnancy ≥32 weeks * American Society of Anesthesiologists physical status classification II to III * Scheduled for cesarean section under spinal anesthesia

Exclusion criteria

* Baseline blood pressure ≥180 mmHg * Body height \< 150 cm * Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2 * Eclampsia or chronic hypertension * Hemoglobin \< 7g/dl * Fetal distress, or known fetal developmental anomaly

Design outcomes

Primary

MeasureTime frameDescription
Cardiac output (CO)1-30 minutes after spinal anesthesiaEvaluated by the VIGILCO monitoring system
Stroke volume (SV)1-30 minutes after spinal anesthesiaEvaluated by the VIGILCO monitoring system
Systemic vascular resistance (SVR)1-30 minutes after spinal anesthesiaEvaluated by the VIGILCO monitoring system

Secondary

MeasureTime frameDescription
The incidence of severe post-spinal anesthesia hypotension.1-30 minutes after spinal anesthesia.Systolic blood pressure (SBP) \< 60% of the baseline
The incidence of hypertension.1-30 minutes after spinal anesthesiaSystolic blood pressure (SBP) \>120% of the baseline.
The incidence of bradycardia.1-30 minutes after spinal anesthesiaHeart rate \< 60 beats/min.
The incidence of nausea and vomiting.1-30 minutes after spinal anesthesiaPresence of nausea and vomiting in patients after spinal anesthesia
Overall stability of systolic blood pressure control versus baseline1-30 minutes after spinal anesthesiaEvaluated by performance error (PE)
Partial pressure of oxygen (PO2)Immediately after deliveryFrom umbilical arterial blood gases.
Base excess (BE)Immediately after deliveryFrom umbilical arterial blood gases.
APGAR score1 min after deliveryA= Appearance P=Pulse G=Grimace A=Attitude R=Respiration
pHImmediately after deliveryFrom umbilical arterial blood gases.
Overall stability of heart rate control versus baseline1-30 minutes after spinal anesthesiaEvaluated by performance error (PE)
The incidence of post-spinal anesthesia hypotension1-30 minutes after spinal anesthesia.Systolic blood pressure (SBP) \< 80% of the baseline

Countries

China

Contacts

Primary ContactXinli Ni, Dr.
xinlini6@nyfy.com.cn86-951-674-3252
Backup ContactYi Chen, M.D.
czzyxgp@163.com86-951-674-3252

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026